Phase II single-arm study of the combination of palbociclib and cetuximab in KRAS/NRAS/BRAF wild-type metastatic colorectal cancer

IRB/UVA Tracking #
20827
Contact
Linsey Jackson
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Matthew Reilley
Status
OPEN TO ACCRUAL